240 related articles for article (PubMed ID: 9324703)
1. [New drugs in the treatment of respiratory allergic diseases].
Gani F; Senna G; Crivellaro M; Dama A; Castellani L; Mezzelani P
Recenti Prog Med; 1997; 88(7-8):333-41. PubMed ID: 9324703
[TBL] [Abstract][Full Text] [Related]
2. [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma].
Benitez HH; Arvizu VM; Gutiérrez DJ; Fogelbach GA; Castellanos Olivares A; Vázquez Nava F; Velázquez HC; González Pérez Mdel C; Mora Nieto A; Rodríguez EC
Rev Alerg Mex; 2005; 52(2):90-5. PubMed ID: 16158782
[TBL] [Abstract][Full Text] [Related]
3. [Antiallergy drugs and respiratory diseases in children].
Donato L; Kuhn P; Cerveau C; Charles X; Chognot D
Arch Pediatr; 1999; 6 Suppl 1():98S-104S. PubMed ID: 10191933
[TBL] [Abstract][Full Text] [Related]
4. [Rhinoconjunctivitis. Highly selective therapy using topical H1-blockers].
HNO; 1996 Mar; 44(3 Suppl):1-4. PubMed ID: 9022382
[No Abstract] [Full Text] [Related]
5. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis.
Dechant KL; Goa KL
Drugs; 1991 Feb; 41(2):202-24. PubMed ID: 1709851
[TBL] [Abstract][Full Text] [Related]
6. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
Noble S; McTavish D
Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
[TBL] [Abstract][Full Text] [Related]
7. Onset of action, effectiveness and tolerance of levocabastine and nedocromil in topical therapy of seasonal allergic rhinoconjunctivitis. The Deutsche Rhinitis-Studiengruppe.
Kremer B; Tündermann A; Goldschmidt O
Arzneimittelforschung; 1998 Sep; 48(9):924-30. PubMed ID: 9793620
[TBL] [Abstract][Full Text] [Related]
8. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
Janssens MM
Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
[TBL] [Abstract][Full Text] [Related]
9. Management of allergic rhinitis: focus on intranasal agents.
Dushay ME; Johnson CE
Pharmacotherapy; 1989; 9(6):338-50. PubMed ID: 2575739
[TBL] [Abstract][Full Text] [Related]
10. [Fluticasone propionate--a new name common in asthma and rhinitis].
Ulmeanu R; Mihălţan F
Pneumoftiziologia; 1997; 46(1):63-4. PubMed ID: 9289240
[No Abstract] [Full Text] [Related]
11. Treating severe eye allergy.
Verin P
Clin Exp Allergy; 1998 Dec; 28 Suppl 6():44-8. PubMed ID: 9988435
[TBL] [Abstract][Full Text] [Related]
12. New therapies for allergic rhinitis.
Braido F; Sclifò F; Ferrando M; Canonica GW
Curr Allergy Asthma Rep; 2014 Apr; 14(4):422. PubMed ID: 24504526
[TBL] [Abstract][Full Text] [Related]
13. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis.
Hung CH; Hua YM; Hsu WT; Lai YS; Yang KD; Jong YJ; Chu YT
Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829
[TBL] [Abstract][Full Text] [Related]
14. A comparison of budesonide nasal dry powder with fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis.
Andersson M; Berglund R; Greiff L; Hammarlund A; Hedbys L; Malcus I; Nilsson P; Olsson P; Sjölin IL; Synnerstad B
Rhinology; 1995 Mar; 33(1):18-21. PubMed ID: 7784789
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis.
Wilson AM; Sims EJ; Orr LC; Coutie WJ; White PS; Gardiner Q; Lipworth BJ
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):344-9. PubMed ID: 11686428
[TBL] [Abstract][Full Text] [Related]
16. The effect of topical nasal fluticasone on objective sleep testing and the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis.
Craig TJ; Mende C; Hughes K; Kakumanu S; Lehman EB; Chinchilli V
Allergy Asthma Proc; 2003; 24(1):53-8. PubMed ID: 12635578
[TBL] [Abstract][Full Text] [Related]
17. Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms.
Ahluwalia P; Anderson DF; Wilson SJ; McGill JI; Church MK
J Allergy Clin Immunol; 2001 Sep; 108(3):449-54. PubMed ID: 11544467
[TBL] [Abstract][Full Text] [Related]
18. [Second generation topical antihistaminics].
Pietrzkowicz M; Grzelewska-Rzymowska I
Pol Merkur Lekarski; 1999 May; 6(35):277-80. PubMed ID: 10437402
[TBL] [Abstract][Full Text] [Related]
19. Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis.
Janssens MM; Vanden Bussche G
Clin Exp Allergy; 1991 May; 21 Suppl 2():29-36. PubMed ID: 1680536
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments.
Nathan RA
Ann Allergy Asthma Immunol; 2003 Feb; 90(2):182-90; quiz 190-1, 232. PubMed ID: 12602664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
